U.S. Stocks on the Move | Novo Nordisk (NVO.US) Surges Over 6% as Q3 Results Beat Expectations and Full-Year Guidance Raised

Zhitong Finance APP has learned that on Wednesday, Novo Nordisk (NVO.US) rose more than 6% to $42.64. On the news front, on November 4, Novo Nordisk's reported financial results showed that third-quarter adjusted sales reached DKK 79.2 billion, higher than the market expectation of DKK 73.55 billion; adjusted EBIT was DKK 31.72 billion, also significantly exceeding the expected DKK 28.71 billion.